Novel metabolic role for BDNF in pancreatic β-cell insulin secretion.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 04 2020
Historique:
received: 25 06 2019
accepted: 26 03 2020
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 1 8 2020
Statut: epublish

Résumé

BDNF signaling in hypothalamic circuitries regulates mammalian food intake. However, whether BDNF exerts metabolic effects on peripheral organs is currently unknown. Here, we show that the BDNF receptor TrkB.T1 is expressed by pancreatic β-cells where it regulates insulin release. Mice lacking TrkB.T1 show impaired glucose tolerance and insulin secretion. β-cell BDNF-TrkB.T1 signaling triggers calcium release from intracellular stores, increasing glucose-induced insulin secretion. Additionally, BDNF is secreted by skeletal muscle and muscle-specific BDNF knockout phenocopies the β-cell TrkB.T1 deletion metabolic impairments. The finding that BDNF is also secreted by differentiated human muscle cells and induces insulin secretion in human islets via TrkB.T1 identifies a new regulatory function of BDNF on metabolism that is independent of CNS activity. Our data suggest that muscle-derived BDNF may be a key factor mediating increased glucose metabolism in response to exercise, with implications for the treatment of diabetes and related metabolic diseases.

Identifiants

pubmed: 32327658
doi: 10.1038/s41467-020-15833-5
pii: 10.1038/s41467-020-15833-5
pmc: PMC7181656
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
Protein Isoforms 0
Receptor, trkB EC 2.7.10.1
Glucose IY9XDZ35W2
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1950

Subventions

Organisme : NIDDK NIH HHS
ID : U24 DK098085
Pays : United States

Références

Rorsman, P. & Braun, M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 75, 155–179 (2013).
pubmed: 22974438 doi: 10.1146/annurev-physiol-030212-183754
Huang, E. J. & Reichardt, L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609–642 (2003).
pubmed: 12676795 doi: 10.1146/annurev.biochem.72.121801.161629
Minichiello, L. TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10, 850–860 (2009).
pubmed: 19927149 doi: 10.1038/nrn2738
Tessarollo, L. Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev. 9, 125–137 (1998).
pubmed: 9754707 doi: 10.1016/S1359-6101(98)00003-3
Chao, M. V., Rajagopal, R. & Lee, F. S. Neurotrophin signalling in health and disease. Clin. Sci. 110, 167–173 (2006).
pubmed: 16411893 doi: 10.1042/CS20050163 pmcid: 16411893
Gray, J. et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55, 3366–3371 (2006).
pubmed: 17130481 pmcid: 2413291 doi: 10.2337/db06-0550
Xu, B. & Xie, X. Neurotrophic factor control of satiety and body weight. Nat. Rev. Neurosci. 17, 282–292 (2016).
pubmed: 27052383 pmcid: 4898883 doi: 10.1038/nrn.2016.24
Yeo, G. S. et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187–1189 (2004).
pubmed: 15494731 doi: 10.1038/nn1336 pmcid: 15494731
Rios, M. BDNF and the central control of feeding: accidental bystander or essential player? Trends Neurosci. 36, 83–90 (2013).
pubmed: 23333344 pmcid: 3568936 doi: 10.1016/j.tins.2012.12.009
Tonra, J. R. et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes 48, 588–594 (1999).
pubmed: 10078561 doi: 10.2337/diabetes.48.3.588
Dupont-Versteegden, E. E. et al. Exercise-induced gene expression in soleus muscle is dependent on time after spinal cord injury in rats. Muscle Nerve 29, 73–81 (2004).
pubmed: 14694501 doi: 10.1002/mus.10511
Gomez-Pinilla, F., Ying, Z., Opazo, P., Roy, R. R. & Edgerton, V. R. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur. J. Neurosci. 13, 1078–1084 (2001).
pubmed: 11285004 doi: 10.1046/j.0953-816x.2001.01484.x
Matthews, V. B. et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52, 1409–1418 (2009).
pubmed: 19387610 doi: 10.1007/s00125-009-1364-1
Chacon-Fernandez, P. et al. Brain-derived neurotrophic factor in megakaryocytes. J. Biol. Chem. 291, 9872–9881 (2016).
pubmed: 27006395 pmcid: 4858990 doi: 10.1074/jbc.M116.720029
Fujimura, H. et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost. 87, 728–734 (2002).
pubmed: 12008958 doi: 10.1055/s-0037-1613072 pmcid: 12008958
Lommatzsch, M. et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 26, 115–123 (2005).
pubmed: 15585351 doi: 10.1016/j.neurobiolaging.2004.03.002 pmcid: 15585351
Stoilov, P., Castren, E. & Stamm, S. Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem. Biophys. Res. Commun. 290, 1054–1065 (2002).
pubmed: 11798182 doi: 10.1006/bbrc.2001.6301 pmcid: 11798182
Eizirik, D. L. et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 8, e1002552 (2012).
pubmed: 22412385 pmcid: 3297576 doi: 10.1371/journal.pgen.1002552
Kitamura, T. The role of FOXO1 in beta-cell failure and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 9, 615–623 (2013).
pubmed: 23959366 doi: 10.1038/nrendo.2013.157 pmcid: 23959366
Fulgenzi, G. et al. BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activation. J. Cell Biol. 210, 1003–1012 (2015).
pubmed: 26347138 pmcid: 4576863 doi: 10.1083/jcb.201502100
Rose, C. R. et al. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 426, 74–78 (2003).
pubmed: 14603320 doi: 10.1038/nature01983 pmcid: 14603320
Zariwala, H. A. et al. A Cre-dependent GCaMP3 reporter mouse for neuronal imaging in vivo. J. Neurosci. 32, 3131–3141 (2012).
pubmed: 22378886 pmcid: 3315707 doi: 10.1523/JNEUROSCI.4469-11.2012
Gilon, P., Chae, H. Y., Rutter, G. A. & Ravier, M. A. Calcium signaling in pancreatic beta-cells in health and in Type 2 diabetes. Cell Calcium 56, 340–361 (2014).
pubmed: 25239387 doi: 10.1016/j.ceca.2014.09.001 pmcid: 25239387
Gilon, P. & Henquin, J. C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr. Rev. 22, 565–604 (2001).
pubmed: 11588141 pmcid: 11588141
Poitout, V. et al. Morphological and functional characterization of beta TC-6 cells—an insulin-secreting cell line derived from transgenic mice. Diabetes 44, 306–313 (1995).
pubmed: 7533732 doi: 10.2337/diab.44.3.306 pmcid: 7533732
Teillon, S., Calderon, G. A. & Rios, M. Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor. J. Endocrinol. 205, 37–47 (2010).
pubmed: 20097691 doi: 10.1677/JOE-09-0405 pmcid: 20097691
McMahon, D. K. et al. C2C12 cells: biophysical, biochemical, and immunocytochemical properties. Am. J. Physiol. 266, C1795–1802 (1994).
pubmed: 8023908 doi: 10.1152/ajpcell.1994.266.6.C1795 pmcid: 8023908
Cuppini, R. et al. BDNF expression in rat skeletal muscle after acute or repeated exercise. Arch. Ital. Biol. 145, 99–110 (2007).
pubmed: 17639782 pmcid: 17639782
Ogborn, D. I. & Gardiner, P. F. Effects of exercise and muscle type on BDNF, NT-4/5, and TrKB expression in skeletal muscle. Muscle Nerve 41, 385–391 (2010).
pubmed: 19813200 doi: 10.1002/mus.21503 pmcid: 19813200
Mousavi, K. & Jasmin, B. J. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J. Neurosci. 26, 5739–5749 (2006).
pubmed: 16723531 pmcid: 6675269 doi: 10.1523/JNEUROSCI.5398-05.2006
Lyons, W. E. et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl Acad. Sci. USA 96, 15239–15244 (1999).
pubmed: 10611369 doi: 10.1073/pnas.96.26.15239
Yang, H., An, J. J., Sun, C. & Xu, B. Regulation of energy balance via BDNF expressed in nonparaventricular hypothalamic neurons. Mol. Endocrinol. 30, 494–503 (2016).
pubmed: 27003443 pmcid: 4853567 doi: 10.1210/me.2015-1329
Radka, S. F., Holst, P. A., Fritsche, M. & Altar, C. A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 709, 122–301 (1996).
pubmed: 8869564 doi: 10.1016/0006-8993(95)01321-0
Naegelin, Y. et al. Measuring and validating the levels of brain-derived neurotrophic factor in human serum. eNeuro https://doi.org/10.1523/ENEURO.0419-17.2018 (2018).
Ono, M. et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem. Biophys. Res. Commun. 238, 633–637 (1997).
pubmed: 9299565 doi: 10.1006/bbrc.1997.7220
Hanyu, O. et al. Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism. Diabetes Obes. Metab. 5, 27–37 (2003).
pubmed: 12542722 doi: 10.1046/j.1463-1326.2003.00238.x pmcid: 12542722
Gilon, P., Jonas, J. C. & Henquin, J. C. Culture duration and conditions affect the oscillations of cytoplasmic calcium concentration induced by glucose in mouse pancreatic islets. Diabetologia 37, 1007–1014 (1994).
pubmed: 7851679 doi: 10.1007/BF00400464 pmcid: 7851679
Fernandes, B. S. et al. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. 13, 289 (2015).
pubmed: 26621529 pmcid: 4666054 doi: 10.1186/s12916-015-0529-7
Kaess, B. M. et al. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J. Am. Heart Assoc. 4, e001544 (2015).
pubmed: 25762803 pmcid: 4392437 doi: 10.1161/JAHA.114.001544
Munkholm, K., Vinberg, M. & Kessing, L. V. Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol. Psychiatry 21, 216–228 (2016).
pubmed: 26194180 doi: 10.1038/mp.2015.54 pmcid: 26194180
Sandrini, L. et al. Association between obesity and circulating brain-derived neurotrophic factor (BDNF) levels: systematic review of literature and meta-analysis. Int. J. Mol. Sci. https://doi.org/10.3390/ijms19082281 (2018).
Qin, X. Y. et al. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer’s disease: a meta-analysis study (N=7277). Mol. Psychiatry 22, 312–320 (2017).
pubmed: 27113997 doi: 10.1038/mp.2016.62 pmcid: 27113997
Dorsey, S. G. et al. In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron 51, 21–28 (2006).
pubmed: 16815329 doi: 10.1016/j.neuron.2006.06.009 pmcid: 16815329
Liebl, D. J., Klesse, L. J., Tessarollo, L., Wohlman, T. & Parada, L. F. Loss of brain-derived neurotrophic factor-dependent neural crest-derived sensory neurons in neurotrophin-4 mutant mice. Proc. Natl Acad. Sci. USA 97, 2297–2302 (2000).
pubmed: 10681461 doi: 10.1073/pnas.040562597 pmcid: 10681461
Thorens, B. et al. Ins1(Cre) knock-in mice for beta cell-specific gene recombination. Diabetologia 58, 558–565 (2015).
pubmed: 25500700 doi: 10.1007/s00125-014-3468-5 pmcid: 25500700
Rios, M. et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748–1757 (2001).
pubmed: 11579207 doi: 10.1210/mend.15.10.0706 pmcid: 11579207
Marciniak, A. et al. Using pancreas tissue slices for in situ studies of islet of Langerhans and acinar cell biology. Nat. Protoc. 9, 2809–2822 (2014).
pubmed: 25393778 doi: 10.1038/nprot.2014.195 pmcid: 25393778
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 pmcid: 22743772 doi: 10.1038/nmeth.2019
Zhu, L. et al. beta-arrestin-2 is an essential regulator of pancreatic beta-cell function under physiological and pathophysiological conditions. Nat. Commun. 8, 14295 (2017).
pubmed: 28145434 pmcid: 5296650 doi: 10.1038/ncomms14295
Golson, M. L., Bush, W. S. & Brissova, M. Automated quantification of pancreatic beta-cell mass. Am. J. Physiol. Endocrinol. Metab. 306, E1460–1467 (2014).
pubmed: 24760991 pmcid: 4059986 doi: 10.1152/ajpendo.00591.2013

Auteurs

Gianluca Fulgenzi (G)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Zhenyi Hong (Z)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Francesco Tomassoni-Ardori (F)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Luiz F Barella (LF)

Molecular Signaling Section, Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, USA.

Jodi Becker (J)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Colleen Barrick (C)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Deborah Swing (D)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Sudhirkumar Yanpallewar (S)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Brad St Croix (BS)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA.

Jürgen Wess (J)

Molecular Signaling Section, Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, USA.

Oksana Gavrilova (O)

Mouse Metabolism Core Laboratory, NIDDK, NIH, Bethesda, USA.

Lino Tessarollo (L)

Mouse Cancer Genetics Program, CCR, NCI, NIH, Frederick, USA. tessarol@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH